Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Deloitte
Boehringer Ingelheim
Johnson and Johnson
Covington
Queensland Health
Accenture
Fish and Richardson
Moodys
Express Scripts

Generated: August 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017830

« Back to Dashboard
NDA 017830 describes LODOSYN, which is a drug marketed by Aton and is included in one NDA. It is available from four suppliers. Additional details are available on the LODOSYN profile page.

The generic ingredient in LODOSYN is carbidopa. There are eighteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the carbidopa profile page.

Summary for NDA: 017830

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 017830

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LODOSYN
carbidopa
TABLET;ORAL 017830 NDA KAISER FOUNDATION HOSPITALS 0179-0125 0179-0125-70 30 TABLET in 1 BOX, UNIT-DOSE (0179-0125-70)
LODOSYN
carbidopa
TABLET;ORAL 017830 NDA AUTHORIZED GENERIC KAISER FOUNDATION HOSPITALS 0179-0226 0179-0226-70 30 TABLET in 1 BOX, UNIT-DOSE (0179-0226-70)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 017830

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aton
LODOSYN
carbidopa
TABLET;ORAL017830-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Aton
LODOSYN
carbidopa
TABLET;ORAL017830-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Aton
LODOSYN
carbidopa
TABLET;ORAL017830-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Novartis
Harvard Business School
AstraZeneca
Merck
Citi
Dow
Baxter
UBS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot